You called it Lara:(Note:BCA now trading as...

You called it Lara:
(Note:BCA now trading as VEA)

ANN:

VEA
30/01/2007
GENERAL


GENERAL: VEA: Indicative non - binding Private Equity Proposal

Indicative non - binding Private Equity Proposal

ASX/NZX ANNOUNCEMENT Tuesday 30 January 2007

Veda Advantage Limited (ASX: VEA) advises that it has received an indicative,
non-binding and conditional proposal from a private equity consortium
comprising Pacific Equity Partners and Merrill Lynch Global Private Equity
(the "Consortium") in respect of a potential privatisation of the company.
Receipt of the Consortium's proposal has followed a period of preliminary
interaction between Veda Advantage and the Consortium.
The Consortium's proposal is at an indicative price of $3.61 per share for
100% of the shares of the company, adjusted for any future dividends.

The Board has agreed the proposal has sufficient merit to provide the
Consortium with due diligence access. The Board's focus is to maximise
shareholder value and accordingly it will facilitate any proposal which it
believes is in the best interest of shareholders, having regard to the
Company's current strategic plans.

The Consortium has indicated to the Board that it intends to work
expeditiously with the company to determine whether a definitive proposal can
be developed. The Consortium has indicated that this is achievable within 4-6
weeks.

The Board has agreed to reimburse the Consortium's reasonable third party due
diligence costs incurred from today's date under certain circumstances. These
costs will be payable in the event that the Consortium confirms following due
diligence that it is prepared to proceed at a price not less than $3.61 per
share, but the Board recommends a competing proposal to shareholders within 6
months of today's date.

There is currently no proposal capable of the Board considering recommending
or putting to shareholders for consideration, nor is there any certainty that
any binding proposal will be received from the Consortium or any other party
at any future time. Despite the ongoing nature of discussions with the
Consortium, shareholders should be cautious about drawing any inference about
whether any binding proposal will eventuate, including potential pricing.

1 The indicative price of $3.61 per share represents a 32% premium to Veda
Advantage's 3 month volume weighted average price up until close of trading
on Monday 29 January 2007, of $2.73 per share.

The Board has appointed Caliburn as financial adviser and Mallesons Stephen
Jaques as legal adviser to assist in consideration of the indicative proposal
and any other proposal that may be received.

In compliance with its continuous disclosure obligations, Veda Advantage will
keep shareholders informed of any material developments.